Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-21

FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc., granting approval for changes under the supplem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDERAL LA (Propranolol hydrochloride)

Snippet

SUPPL AP for INDERAL LA (PROPRANOLOL HYDROCHLORIDE)